Concepedia

Sivaraman Dandapani

SD

Statistics

Publications

40

Citations

2.2K

H-Index

23

Active since

2002

Affiliations

Broad Institute(Current)

Howard Hughes Medical Institute

Harvard University

Massachusetts Institute of Technology

University of Pittsburgh

Sivaraman Dandapani is an author at Broad Institute specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

2002–2022

40

Publications

40

Development of small-molecule probes that selectively kill cells induced to express mutant RAS

Michel Weïwer, Joshua A. Bittker, Timothy A. Lewis et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 238 citations

, , +13

An Aldol-Based Build/Couple/Pair Strategy for the Synthesis of Medium- and Large-Sized Rings: Discovery of Macrocyclic Histone Deacetylase Inhibitors

Lisa A. Marcaurelle, Eamon Comer, Sivaraman Dandapani et al. · Journal of the American Chemical Society · 2010 · 213 citations · Full text

, , +17

Grand Challenge Commentary: Accessing new chemical space for 'undruggable' targets

Sivaraman Dandapani, Lisa A. Marcaurelle · Nature Chemical Biology · 2010 · 209 citations

, , +14

Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction

Longqin Hu, Sadagopan Magesh, Lin Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 200 citations · Full text

, , +14

A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells

Michel Weïwer, James Spoonamore, Jingqiang Wei et al. · ACS Medicinal Chemistry Letters · 2012 · 147 citations · Full text

, , +15

1–5 of 40